Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapiglutide for the treatment of obesity (DREAM)
2022-501649-54-01Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Apr 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Dapiglutide with Placebo (2 arms). Started Apr 2023; status: completed.
02
Drugs
dapiglutide
03
Conditions
obesity
Beyond the preview
Go deeper on 2022-501649-54-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501649-54-01.